Bronchodilator effect on O2 deficit and V'O2 kinetics during moderate intensity exercise in normoxemic COPD [chronic obstructive pulmonary disease]

Trial Profile

Bronchodilator effect on O2 deficit and V'O2 kinetics during moderate intensity exercise in normoxemic COPD [chronic obstructive pulmonary disease]

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Apr 2011

At a glance

  • Drugs Salbutamol/ipratropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Apr 2011 Status changed from recruiting to completed, according to ClinicalTrials.gov.
    • 22 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top